当地时间8月30日-9月2日，2024年欧洲心脏病学会年会（ESC 2024）将于英国伦敦拉开帷幕，并同步举办线上会议。今年大会聚焦“个性化心血管护理”，为期4天的会议设置26场Late-Breaking Science专场（共163项研究）。届时，严道医声网将持续跟踪报道，并邀请专家进行解读，部分日程早知道，其余最新信息邀您持续关注。

Late-Breaking Science

GLP-1受体激动剂司美格鲁肽的临床试验进展

北京时间：8月30日 15:15-16:45

Atrial fibrillation and efficacy of semaglutide 2.4 mg in obesity-related HFpEF: A Patient Level Pooled analysis of STEP-HFpEF and STEP-HFpEF DM trials

心房颤动和2.4 mg司美格鲁肽治疗肥胖相关HFpEF的疗效：STEP-HFpEF和STEP-HFpEF-DM试验的患者水平汇总分析

Inflammation in obesity-related HFpEF: the STEP-HFpEF programme

肥胖相关HFpEF的炎症：STEP-HFpEF计划

STEP-HFpEF Program Echocardiography Substudy

STEP-HFpEF计划超声心动图子研究

Effects of the GLP-1 receptor agonist, semaglutide, on heart failure outcomes: a pre-specified analysis of the FLOW trial in participants with type 2 diabetes and chronic kidney disease

GLP-1受体激动剂司美格鲁肽对心力衰竭结局的影响：FLOW试验中2型糖尿病合并慢性肾脏疾病参与者的预先指定分析

Semaglutide and cardiovascular outcomes in females with overweight and obesity: A prespecified analysis of the SELECT trial

司美格鲁肽与超重和肥胖女性心血管结局：SELECT试验的预先指定分析

The effect of semaglutide on mortality and COVID-19-related deaths - a pre-specified analysis from the SELECT trial

司美格鲁肽对死亡率和COVID-19相关死亡的影响——SELECT试验的预先指定分析

Semaglutide and cardiovascular outcomes by baseline chronic kidney disease status and albuminuria in type 2 diabetes and chronic kidney disease: results from the FLOW trial

基线慢性肾脏疾病状态合并蛋白尿的2型糖尿病合并慢性肾脏疾病患者应用司美格鲁肽的心血管结局：FLOW试验结果

Effects of semaglutide on clinical events in heart failure with preserved ejection fraction: a pooled, participant-level analysis of SELECT, FLOW, STEP-HFpEF and STEP-HFpEF DM trials

司美格鲁肽对射血分数保留型心力衰竭患者临床事件的影响：SELECT、FLOW、STEP-HFpEF和STEP-HFpEF DM试验的参与者水平汇总分析

心血管疾病炎症和免疫的小型试验、试验更新和其他研究

北京时间：8月30日 15:15-16:45

Low-dose interleukin-2 for the reduction of vascular inflammation in acute coronary syndromes (IVORY) / IVORY - Clinical Outcomes And Follow-up (IVORY FINALE) Study

低剂量白细胞介素-2减少急性冠状动脉综合征血管炎症：IVORY临床结果和随访（IVORY FINALE）研究

Anakinra versus placebo double blind Randomized controlled trial for the treatment of Acute MyocarditIS

阿那白滞素 vs. 安慰剂治疗急性心肌梗死的双盲随机对照试验

Colchicine for secondary prevention of stroke and other cardiovascular events: a meta-analysis of randomised trials

秋水仙碱用于卒中和其他心血管事件的二级预防：一项随机试验的荟萃分析

Cardiovascular benefit of colchicine in relation to baseline risk

秋水仙碱的心血管益处与基线风险的关系

Effect of pre-hospital pulse-dose glucocorticoid on infarct size in st-segment elevation myocardial infarction: a randomized, blinded, placebo-controlled clinical trial

院前脉冲剂量糖皮质激素对ST段抬高型心肌梗死患者梗死面积的影响：一项随机、盲法、安慰剂对照的临床试验

Randomized double-blind trial to study the benefit of Colchicine in Patients with Acutely Decompensated Heart Failure

秋水仙碱治疗急性失代偿性心力衰竭的随机双盲试验

Intravenous immunoglobulin therapy improves long-term outcome in dilated cardiomyopathy by modulating cardiac immune cell function. An update of a randomized placebo-controlled study.

静脉注射免疫球蛋白通过调节心脏免疫细胞功能改善扩张型心肌病的长期疗效：一项随机安慰剂对照研究的最新进展

Effect of short-term prednisone therapy on C-reactive protein change in emergency department patients with acute heart failure and elevated inflammatory markers

短期泼尼松治疗对急诊科急性心力衰竭合并炎症标志物升高患者C反应蛋白变化的影响

TAVI的登记、观察和其他研究

北京时间：8月30日 20:45-22:00

Long-term structural valve deterioration after TAVI: insights from the European Valve Durability TAVI registry

TAVI后的长期结构性瓣膜退化：来自欧洲瓣膜耐久性TAVI注册研究的见解

Long-term benefit of isolated surgical tricuspid valve repair and replacement in patients with severe functional tricuspid regurgitation: Impact of the TRI-SCORE

严重功能性三尖瓣反流患者单独三尖瓣修复术 vs. 三尖瓣置换术的长期获益：TRI-SCORE的影响

SAVR and TAVI comparison across the Globe based on current regional registry evidence - a meta-analysis of reconstructed time-to-event data

基于当前区域注册证据的全球SAVR和TAVI比较——重建时间-事件数据的荟萃分析

Aortic valve calcific volume by computed tomography angiography in patients with aortic stenosis

主动脉狭窄患者主动脉瓣钙化体积的计算机断层造影

Serial volumetric assessment of ascending aort dilatation in severe aortic stenosis patients who receive Transcatheter aortic valve replacement: Comparison of bicuspid and tricuspid aortic stenosis

接受经导管主动脉瓣置换术的严重主动脉狭窄患者升主动脉瓣扩张的系列容积评估：二叶式和三叶式主动脉瓣狭窄的比较

Sex related differences in frequency, management and outcome of severe native valvular heart disease. Results from the ESC-EORP Valvular Heart Disease II survey

ESC-EORP瓣膜性心脏病II调查结果：严重先天性瓣膜性心脏病的发病率、治疗和转归的性别差异

人工智能的注册、观测和其他研究

北京时间：8月30日 20:45-22:00

Artificial intelligence-based prediction of mortality, bleeding, and ischaemic events in cancer patients with acute coronary syndrome: A modelling study in the UK and Switzerland

基于人工智能的癌症合并急性冠状动脉综合征患者死亡率、出血和缺血性事件预测：英国和瑞士的一项模型研究

Artificial intelligence for analysis of ambulatory electrocardiography

人工智能在动态心电图分析中的应用

Heart Failure detection using Artificial Intelligence for diagnostic decision support applied to echocardiography - HFDetect-AI

基于人工智能的心力衰竭检测，用于超声心动图的诊断决策支持——HFDetect-AI研究

MitrAI score: machine learning models to predict mortality at 12, 24, 36 and 48 months in patients with primary and secondary mitral regurgitation treated by transcatheter edge-to-edge repair.

MitrAI评分：机器学习模型预测经导管缘对缘修复术治疗的原发性和继发性二尖瓣反流患者在12、24、36和48个月时的死亡率

Machine-learning based scoring system to predict cardiogenic shock in acute coronary syndrome

基于机器学习的评分系统预测急性冠状动脉综合征心源性休克

Machine learning algorithm using point-of-care high-sensitivity cardiac troponin I for rapid rule-out of myocardial infarction

使用床旁（point-of-care）高敏肌钙蛋白I的机器学习算法快速排除心肌梗死

心力衰竭的小型试验、试验更新和其他研究（1）

北京时间：8月30日 23:15-00:15

The effect of dapagliflozin on accelerometer-based measures of physical activity in heart failure: an exploratory analysis of the DETERMINE trials

达格列净对心力衰竭患者基于加速度计的体力活动测量的影响：对DETERMINE试验的探索性分析

Synchronized left ventricular pacing improves cardiac resynchronization therapy outcomes: insights from AdaptResponse

同步左心室起搏改善心脏再同步治疗结果：AdaptResponse的见解

Catheter ablation in end-stage heart failure with atrial fibrillation: two-year follow-up of the CASTLE-HTx trial

导管消融治疗终末期心力衰竭伴心房颤动：CASTLE-HTx试验的两年随访

A randomised, double-blind, placebo-controlled study to investigate the safety and tolerability of XXB750 in heart failure patients with reduced or mildly reduced ejection fraction

XXB750治疗射血分数降低或轻度降低的心力衰竭患者安全性和耐受性的随机、双盲、安慰剂对照研究

Rapid detection of incident heart failure by artificial intelligence: lessons from the NIL-CHF trial

人工智能快速检测心力衰竭事件：NIL-CHF试验的经验教训

重点登记、观察和其他研究

北京时间：8月31日 15:15-16:45

Nature-AGT: Using Causal AI to estimate the optimal timing of lowering SBP with an siRNA directed against angiotensinogen to reduce the lifetime risk of cardiovascular events

Nature-AGT研究——使用Causal AI评估针对血管紧张素原的siRNA降低收缩压的最佳时机，以降低心血管事件的终身风险

Thirty-year cardiovascular outcomes in women based on C-reactive protein, LDL cholesterol, and lipoprotein(a)

基于C反应蛋白、低密度脂蛋白胆固醇和脂蛋白(a)的女性30年心血管结局

Economic Toll of Cardiovascular Disease on Healthcare and Mortality in 50 ESC member countries

50个ESC成员国心血管疾病对医疗保健和死亡率的经济影响

Incidental and progressive tobacco smoking from childhood through young adulthood with premature structural and functional cardiac damage in 1931 children: A 14-Year Longitudinal Study

1931例儿童从儿童期到青年期的偶然和渐进吸烟伴过早的结构性和功能性心脏损伤：一项14年的纵向研究

Global Pretest probability study of coronary artery disease

全球冠状动脉疾病预测概率研究

Black carbon: a novel indicator of the risk of acute myocardial infarction associated with short-term exposure to fine particulate matter

Black carbon：短期接触细颗粒物相关急性心肌梗死风险的新指标

Incremental value of cardiac myosin binding protein C to high-sensitivity cardiac troponin for the early diagnosis of acute myocardial infarction

在急性心肌梗死的早期诊断中，心肌肌球蛋白结合蛋白C对高敏肌钙蛋白具有增量价值

Trial of switching high-sensitivity cardiac troponin assays in suspected acute coronary syndrome (TWITCH-ED)

TWIC-HED研究——在疑似急性冠状动脉综合征患者中切换高灵敏度心肌肌钙蛋白检测的试验

关于心力衰竭的小型试验、试验更新和其他研究（2）

北京时间：8月31日 15:15-16:45

Thoracentesis to alleviate pleural effusion in acute heart failure: results from the pragmatic, multi-centre, open-label, randomised controlled TAP-IT trial

胸腔穿刺术缓解急性心力衰竭胸腔积液：实用、多中心、开放标签、随机对照TAP-IT试验的结果

Impact of a pneumococcal vaccination incentive campaign in chronic heart failure patients in France: a randomized clinical trial

肺炎球菌疫苗接种激励活动对法国慢性心力衰竭患者的影响：一项随机临床试验

Early in-hospital initiation of angiotensin-neprilysin inhibition in Japanese patients with acute heart failure: the investigator-initiated multicenter randomized PREMIER study

日本急性心力衰竭患者院内早期启动血管紧张素-肾素抑制剂治疗：研究者发起的多中心随机PREMIER研究

Intensive therapeutic education strategy by specialised nurses for patients with acute Heart Failure: results from the multicentre randomized controlled EDUSTRA-HF trial.

专业护士对急性心力衰竭患者的强化治疗教育策略：多中心随机对照EDUSTRA-HF试验结果

Assessment of Digital consults in heart failure Management on clINical Impact, SafeTy and Efficiency using a RCT (ADMINISTER) trial

ADMINITER研究——使用RCT评估心力衰竭管理中数字咨询的临床影响、安全性和效率

Carvedilol as single maintenance therapy for Heart Failure with Improved Ejection Fraction: an open-label randomized clinical trial CATHEDRAL-HF

卡维地洛作为射血分数改善型心力衰竭的单一维持疗法：一项开放标签随机临床试验CATHEDRAL-HF研究

WITHDRAWal of Heart Failure Pharmacotherapy in Patients with Normalized Left Ventricular Function After AF Rhythm Control in Arrhythmia Induced Cardiomyopathy-The WITHDRAW-AF Randomized Clinical Trial

心律失常性心肌病房颤节律控制后左心室功能正常的患者停止心力衰竭药物治疗：WITHDRAW-AF随机临床试验

Assessment of non-inferiority of a hospital-at-home care pathway for patients with acute heart failure: FIL-EAS-ic

急性心力衰竭患者家庭医院护理途径的非劣效性评估：FIL-EAS-ic研究

关于虚弱、跌倒和少肌症的登记、观察和其他研究

北京时间：8月31日 18:00-19:15

Clinical fraily scale is independently associated with one-year mortality in a large cohort of patients with acute heart disease

在一个大型急性心脏病患者队列中，临床虚弱量表与一年死亡率独立相关

Relevance of frailty in patients with acute coronary syndrome

急性冠状动脉综合征患者虚弱的相关性

Combining frailty into RCRI for prediction perioperative myocardial injury/infarction in patients undergoing noncardiac surgery

将虚弱与RCRI相结合预测非心脏手术患者围手术期心肌损伤/梗死

Impact of sarcopenia on the clinical course of older patients with peripheral artery disease

少肌症对老年外周动脉疾病患者临床病程的影响

History Of Falls is Associated with Management and Worse Prognosis in Patients with Atrial Fibrillation: An Analysis from the Prospective GLORIA-AF Registry Phase III

跌倒史与心房颤动患者的治疗和预后不良相关：来自GLORIA-AF注册III期的前瞻性分析

Feasibility and diagnostic yield of screening for atrial fibrillation with PPG in very old and frail patients. Results from the Dutch-GERAF study.

PPG筛查高龄和体弱患者心房颤动的可行性和诊断率：荷兰GERAF研究结果

冠状动脉疾病的登记、观察和其他研究，包括干预和手术

北京时间：8月31日 20:45-22:00

Temporal trends in the use of drug-coated balloons

药物涂层球囊使用的时间趋势

Ticagrelor monotherapy or DAPT after drug-eluting coronary stenting in patients with or without acute coronary syndrome: a patient-level meta-analysis of randomized controlled trials

患有或不患有急性冠状动脉综合征的患者在药物洗脱支架植入术后接受替格瑞洛单药治疗或DAPT治疗：随机对照试验的患者水平荟萃分析

Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents

接受Xience Sierra依维莫司洗脱支架治疗的复杂患者和糖尿病或糖尿病前期患者

Major adverse cardiovascular events, new diagnoses, prescription redemptions and outpatient visits in patients one year after evaluation for symptoms suggestive of chronic coronary syndrome

评估慢性冠状动脉综合征症状一年后患者的主要心血管不良事件、新诊断、处方换药和门诊就诊

The trajectory of functional recovery after cardiac surgery: a prospective observational cohort study

心脏手术后功能恢复的轨迹：一项前瞻性观察性队列研究

Survival after PCI or CABG for multivessel disease in NSTE-ACS:  a report from the SWEDEHEART registry

NSTE-ACS多支血管病变患者PCI或CABG术后的生存率：SWEDHEART注册研究报告

经皮冠状动脉介入治疗的试验更新和其他研究

北京时间：8月31日 23:15-00:15

Clopidogrel following 1-month aspirin-free low-dose prasugrel monotherapy versus aspirin following 1-month DAPT after PCI for patients with ACS or HBR:  Final 1-year results from the STOPDAPT-3

ACS或HBR患者PCI术后1个月无阿司匹林低剂量的普拉格雷单药治疗后氯吡格雷治疗 vs. 1个月DAPT后阿司匹林治疗：STOPDAPT-3的最终1年结果

Long-Term Outcomes with PCI Guided by Fractional Flow Reserve

FFR引导下PCI的远期疗效

Titanium-nitride-oxide-coated vs drug-eluting stents in acute coronary syndromes during five-year follow-up: an individual patient data meta-analysis

急性冠状动脉综合征中氮氧化钛涂层支架与药物洗脱支架的五年随访：个体数据荟萃分析

Physiology-guided complete versus culprit-only PCI in older MI patients

生理学指导下老年心肌梗死患者完全PCI与单纯罪犯PCI

A comparison of prolonged anticoagulation versus no anticoagulation after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction

ST段抬高型心肌梗死患者直接PCI后延长抗凝 vs. 不抗凝治疗

关于高血压的小型试验、试验更新和其他研究

北京时间：9月1日 00:30-01:30

Renal denervation lowers all-cause and cardiovascular mortality in patients with uncontrolled arterial hypertension: a randomised, sham-controlled study.

RDN降低未控制动脉高压患者的全因死亡率和心血管死亡率：一项随机、假对照研究

Effects of Intensive vs Standard Blood Pressure Control on Cardiovascular Outcomes in Cancer Survivors: Results from the SPRINT Randomized Trial

强化 vs. 标准血压控制对癌症幸存者心血管结局的影响：SPRINT随机试验结果

A machine learning algorithm for personalizing intensive blood pressure treatment: derivation from SPRINT/ACCORD-BP trials and validation in CRHCP, a pragmatic implementation trial

一种用于个性化强化血压治疗的机器学习算法：从SPRINT/ACCORD-BP试验中推导出来，并在CRHCP中验证的一项实用性实施试验

Long-term outcomes of intensive blood-pressure control in older patients with hypertension: final six-year results of the STEP trial

老年高血压患者强化血压控制的长期结果：STEP试验的最终六年结果

Fractional flow reserve to determine the appropriateness of percutaneous renal artery intervention in atherosclerotic renovascular hypertension patients: a randomized trial

FFR确定经皮肾动脉介入治疗动脉粥样硬化性肾血管性高血压患者的适宜性：一项随机试验

小型试验、试验更新和其他研究：心房颤动的检测、预防和治疗

北京时间：9月1日 00:30-01:30

Catheter ablation in persistent atrial fibrillation: long term outcomes of the CAPLA multicentre randomised trial of pulmonary vein isolation(PVI) vs PVI plus posterior left atrial wall isolation(PWI)

导管消融治疗持续性心房颤动：肺静脉隔离（PVI） vs. PVI联合左心房后壁隔离（PWI）——CAPLA多中心随机试验的长期结果

Randomized evaluation of decision support interventions for atrial fibrillation: Anticoagulant adherence after shared decision making interventions for stroke prevention in atrial fibrillation

心房颤动决策支持干预的随机评估：共同决策干预后抗凝药物依从性对房颤卒中预防的影响

Predictors and Outcomes of Atrial Fibrillation Progression in Patients with Device-Detected Subclinical AF: Insights from the ARTESiA Trial

设备检测到的亚临床AF患者心房颤动进展的预测因素和结局：ARTESiA试验的启示

Biomolecule-based prediction of sinus rhythm and interaction with early rhythm control: EAST-AFNET 4 biomolecule study

基于生物分子的窦性心律预测及其与早期心律控制的相互作用：EAST-AFNET 4生物分子研究

The Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients With Heart Failure and Atrial Fibrillation Extend

心力衰竭合并心房颤动患者基于消融的心律控制 vs. 心率控制的随机试验

基础科学与转化科学

北京时间：9月1日 15:15-16:45

Gut Microbiota and Associated Metabolites Play a Key Role in the Pathogenesis of the Obesity Phenotype of Heart Failure With Preserved Ejection Fraction

肠道微生物群和相关代谢物在肥胖表型的射血分数保留型心力衰竭发病机制中发挥关键作用

Distinct cellular and molecular trajectories leading to subclinical diastolic dysfunction and the progression to HFpEF

不同的细胞和分子轨迹导致亚临床舒张功能障碍并进展为HFpEF

Different cardiovascular outcomes of vascular ageing proteomic phenogroups in normotensive and hypertensive individuals: results from the UK Biobank.

血压正常和高血压患者血管老化蛋白质组表型的不同心血管结果：来自英国生物数据库的结果

Polygenic traits and cardiac remodelling contribute to a markedly increased risk of atrial fibrillation in former elite endurance athletes

多基因特征和心脏重塑导致前优秀耐力运动员发生心房颤动的风险显著增加

Echocardiographic screening for cardiac amyloidosis using artificial intelligence: A multi-site study for algorithm training and external validation.

利用人工智能进行心脏淀粉样变的超声心动图筛查：算法训练和外部验证的多站点研究

Echocardiographic screening for cardiac amyloidosis using artificial intelligence: A multi-site study for algorithm training and external validation.

利用人工智能进行心脏淀粉样变的超声心动图筛查：算法训练和外部验证的多站点研究

The role of uremic toxin indoxyl sulfate in aggravated aortic valve stenosis under uremic conditions

尿毒症毒素硫酸吲哚酚在尿毒症条件下加重主动脉瓣狭窄

The individual fibrinolytic potential predicts efficacy of ultrasound-assisted catheter-directed thrombolysis in patients with acute pulmonary embolism

个体纤溶潜能预测超声导管引导溶栓治疗急性肺栓塞的疗效

冠状动脉疾病的小型试验、试验更新和其他研究

北京时间：9月1日 15:15-16:45

Effects of Beta-Blockers on Quality of Life and Well-being in Patients with Myocardial Infarction and Preserved Left Ventricular Function - a prespecified substudy from REDUCE-AMI

β受体阻滞剂对左心室功能保留的心肌梗死患者生活质量和幸福感的影响——REDUCE-AMI的一项预先指定的亚组研究

Short- and long-term effects of beta-blockers on symptoms of anxiety and depression in patients with myocardial infarction and preserved left ventricular function: prespecified substudy from REDUCE-AM

β受体阻滞剂对左心室功能保留的心肌梗死患者焦虑和抑郁症状的短期和长期影响：REDUCE-AM的预先指定亚组研究

Coronary computed tomography angiography guided management of patients with stable chest pain: 10-year outcomes from the SCOT-HEART trial

CCTA指导下稳定型胸痛患者的管理：SCOT-HEART试验的10年结果

Adherence to Nordic and Mediterranean dietary patterns may be associated with a lower absolute risk of incident atherosclerotic cardiovascular disease

坚持北欧和地中海饮食模式可能与动脉粥样硬化性心血管疾病的绝对风险较低有关

Cardiorenal effects and safety of initiation of empagliflozin after acute myocardial infarction

急性心肌梗死后开始服用恩格列净的心肾效应和安全性

Cardiovascular Risk Scoring or CT Angiography for Lifestyle and Risk Factor Modification in Primary Prevention of Cardiovascular Disease The SCOT-HEART 2 IMPACT Study

心血管疾病一级预防中生活方式和风险因素改变的心血管风险评分或CT血管造影——SCOT-HEART 2 IMPACT研究

Rehabilitation at home using mobile health in older adults after hospitalization for ischemic heart disease

老年人缺血性心脏病住院后使用移动健康的家庭康复

Cost-effectiveness and safety of the CADScorSystem in patients with symptoms suggestive of stable coronary artery disease.

CADScorSystem在症状提示稳定型冠状动脉疾病患者中的成本效益和安全性

肥厚型心肌病和主动脉狭窄的试验更新和其他研究

北京时间：9月1日 15:15-16:45

Effect of Aficamten on Patient-Reported Health Status in Obstructive Hypertrophic Cardiomyopathy: Results from SEQUOIA-HCM

Aficasten对梗阻性肥厚型心肌病患者报告健康状况的影响：来自SEQUOIA-HCM研究的结果

Short- and long-term effects of beta-blockers on symptoms of anxiety and depression in Impact of Aficamten on Echocardiographic Cardiac Structure and Function in Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy

Aficasten对成人症状性梗阻性肥厚型心肌病超声心动图心脏结构和功能的影响

Effect of Aficamten on Cardiac Structure and Function in Patients with Obstructive Hypertrophic Cardiomyopathy: The SEQUOIA-HCM CMR Trial

Aficasten对梗阻性肥厚型心肌病患者心脏结构和功能的影响：SEQUOIA-HCM CMR试验

Safety and Outcomes of Standard of Care Medications Withdrawal in Patients with Obstructive Hypertrophic Cardiomyopathy Treated with Aficamten in FOREST-HCM Trial

FOREST-HCM试验中Aficasten治疗阻塞性肥厚型心肌病患者停药的安全性和疗效

Aortic valve replacement versus conservative treatment in asymptomatic severe aortic stenosis

无症状重度主动脉瓣狭窄的主动脉瓣置换术 vs. 保守治疗

Sex-specific outcomes after transcatheter or surgical treatment of aortic valve stenosis:  A subanalysis from the DEDICATE-DZHK6 trial

主动脉瓣狭窄经导管或外科手术治疗后的性别特异性结果：DEDICATE-ZHK6试验的亚组分析

Transcatheter or surgical treatment of aortic valve stenosis in patients with chronic kidney disease: an analysis from the randomized DEDICATE-DZHK 6 trial

经导管或外科手术治疗慢性肾脏病患者主动脉瓣狭窄：来自DEDICATE-ZHK 6随机试验的分析

Development and validation of the ASGARD-S risk score for optimal timing of echocardiograms in asymptomatic patients with non-severe aortic valve stenosis: the SEAS and SALTIRE II trials

ASGARD-S风险评分的开发和验证用于非严重主动脉瓣狭窄无症状患者超声心动图最佳时机：SEAS和SALTIRE II试验

动脉粥样硬化的小型试验和其他研究

北京时间：9月1日 18:00-19:00

Effects of Coronary Artery Calcium-Guided Statin Therapy on Atherosclerotic Progression in Intermediate-Risk People with Familial Coronary Artery Disease

冠状动脉钙引导他汀类药物治疗对家族性冠状动脉疾病中危人群动脉粥样硬化进展的影响

Functional Improvement of non-infarcT relaTed  coronary artery stenosis by Extensive LDL-C Reduction  with a PCSK9 Antibody

PCSK9抗体广泛降低低密度脂蛋白胆固醇改善非梗死相关冠状动脉狭窄的功能

Treatment of periodontitis and progression of subclinical atherosclerosis: a randomized controlled clinical trial

牙周炎的治疗与亚临床动脉粥样硬化的进展：一项随机对照临床试验

Primary Results of SLICE-CEA CardioLink-8: A Randomized Trial of Evolocumab on Carotid Artery Atherosclerotic Plaque Characteristics in People with Asymptomatic High-Risk Carotid Stenosis

SLICE-CEA CardioLink-8研究的主要结果：依洛尤单抗对无症状高危颈动脉狭窄患者颈动脉斑块特征的随机试验

Quantified characterization of atherosclerotic plaques by optical coherence tomography attenuation imaging

OCT衰减成像定量表征动脉粥样硬化斑块

关于脂质的登记、观察和其他研究

北京时间：9月1日 20:45-22:15

LDL-Cholesterol levels and lipid lowering therapy in secondary prevention patients: preliminary data from BRING-UP Prevention Study

二级预防患者的LDL-C水平和降脂治疗：BRING-UP预防研究的初步数据

Suboptimal Lipid Measurement and Statin Use after Percutaneous Coronary Intervention is associated with Increased Mortality: Results of a Real World Registry of 76,264 Patients in NW London

PCI后不佳的脂质测量和他汀类药物使用与死亡率增加相关：伦敦西北部76,264例患者的真实世界登记研究结果

Intensive, early and sustained lowering of atherogenic lipoproteins after myocardial infarction and long-term prognosis: a nationwide cohort study of myocardial infarction patients

心肌梗死后致动脉粥样硬化脂蛋白的强化、早期和持续降低与长期预后：一项全国性心肌梗死患者队列研究

Association of early versus late use of combination lipid-lowering therapy with major cardiovascular outcomes after myocardial infarction: data from the SWEDEHEART registry

早期和晚期联合降脂治疗与心肌梗死后主要心血管结局的关系：SWEDHEART注册数据

A global perspective of Lp(a) levels in patients with coronary heart disease - Implications for risk factor control & future trials from the INTERASPIRE Study

冠心病患者Lp（A）水平的全球视角——INTERASPIRE研究对风险因素控制和未来试验的影响

Optimising oral lipid-lowering therapy regimens in high and very high-risk statin intolerant patients with dyslipidaemia: A French real-world simulation

优化高风险和极高危他汀类药物不耐受且血脂异常患者的口服降脂治疗方案：法国真实世界模拟

小型试验：心脏功能和重塑

北京时间：9月1日 23:15-00:15

Strain sUrveillance during Chemotherapy for improving Cardiovascular Outcomes: Results of a Randomized Trial of Cardioprotection for Reduced Myocardial Strain (SUCCOUR-MRI)

化疗期间的应变监测改善心血管结局：减少心肌应变的心脏保护随机试验结果（SUCCUR-MRI）

Catheter Ablation versus Medical Rate Control in Atrial Fibrillation with Left Ventricular Systolic Dysfunction and Myocardial Fibrosis - The CAMERA-MRI II Randomized Trial

心房颤动伴左心室收缩功能障碍和心肌纤维化的导管消融 vs. 心率控制治疗——CAMERA-MRI II随机试验

Sacubitril/valsartan compared to valsartan in regressing myocardial fibrosis in stage B heart failure: the REVERSE-LVH Trial

沙库巴曲/缬沙坦与缬沙坦逆转B期心力衰竭心肌纤维化的比较：REVERSE-LVH试验

Empagliflozin to prevent worsening of left ventricular volumes and systolic function after myocardial infarction

恩格列净预防心肌梗死后左心室容积和收缩功能恶化

Sacubitril/valsartan in primary prevention of cancer-therapy related cardiac dysfunction in breast cancer patients.

沙库巴曲/缬沙坦在乳腺癌症患者化疗相关心功能不全的一级预防中的作用

冠状动脉疾病和冠状动脉血运重建的小型试验、试验更新和其他研究

北京时间：9月2日 00:30-01:30

Assessment of the microvascular resistance reserve for predicting the effect of revascularization in patients with moderate coronary stenoses.

评估微血管阻力储备预测中度冠状动脉狭窄患者血运重建效果

Long-term effect of biodegradable versus durable polymer drug-eluting stents on neoatherosclerosis among STEMI patients: the international CONNECT randomized controlled intracoronary OCT trial

生物可降解与耐用聚合物药物洗脱支架对STEMI患者新动脉粥样硬化的长期影响：国际CONNECT随机对照冠状动脉内OCT试验

Glycoprotein IIb/IIIa Inhibitors in patients with acute myocardial infarction and angiographic no-reflow: the randomized REVERSE-FLOW trial

糖蛋白IIb/IIIa抑制剂在急性心肌梗死伴血管造影无复流患者中的应用：随机REVERSE-FLOW试验

Evaluation of ambulatory electrocardiographic monitoring of patients after high-risk acute coronary syndrome. A randomized trial.

评价高危急性冠状动脉综合征患者动态心电图监测的随机试验

关于休克、手术和其他干预措施的小型试验和试验更新

北京时间：9月2日 15:15-16:45

Extracorporeal life support for acute myocardial infarction complicated by cardiogenic shock - 12 months results of the ECLS-SHOCK trial

体外生命支持治疗急性心肌梗死并发心源性休克——ECLS-SHOCK试验12个月结果

Temporary mechanical circulatory support in infarct-related cardiogenic shock - An individual patient data meta-analysis of all randomized trials with 6-month follow-up

梗死相关心源性休克的临时机械循环支持——所有随访6个月的随机试验的个体患者数据荟萃分析

Impact of baseline surgical risk on the treatment effect of PCI and CABG in ischemic left ventricular systolic dysfunction: results of the REVIVED-BCIS2 and STICH randomized controlled trials

基线手术风险对PCI和CABG治疗缺血性左心室收缩功能障碍疗效的影响：REVIVED-BICS2和STICH随机对照试验的结果

Comparative Effectiveness of Percutaneous and Surgical Revascularisation in Ischaemic Left Ventricular Systolic Dysfunction: Combined Patient-Level Analysis of the REVIVED-BCIS2 and STICH Trials

经皮和外科手术血运重建治疗缺血性左心室收缩功能障碍的疗效比较：REVIVED-BCIS2和STICH试验的联合患者水平分析

Urgent surgery compared to fibrinolytic therapy for the treatment of left-sided mechanical valve thrombosis (SAFE-PVT): a randomized controlled trial

SAFE-PVT研究——比较急诊手术与溶栓治疗左侧机械瓣膜血栓形成的随机对照试验

Empagliflozin for prevention of acute kidney injury in patients with type 2 diabetes mellitus undergoing extracorporeal on-pump CABG: The POST-CABGDM trial

恩格列净预防2型糖尿病患者体外泵支持下CABG术后急性肾损伤的研究：POST-CABGDM研究

Apixaban versus ClopidoGRel on a background of aspirin in patient undergoing InfraPoPliteal angioplasty for critical limb ischemial

接受膝下血管成形术治疗的危重肢体缺血患者阿司匹林背景下阿哌沙班 vs. 氯吡格雷

Cardiac magnetic resonance imaging vs invasive coronary angiography as primary strategy in heart failure with reduced ejection fraction - A diagnostic randomized trial

心脏磁共振成像与有创冠状动脉造影作为射血分数降低心力衰竭的主要治疗策略——一项诊断性随机试验

小型试验、试验更新和其他研究：装置、心脏骤停和心房颤动消融

北京时间：9月2日 15:15-16:45

Consistent ATP, defibrillation, and safety performance of the extravascular ICD: final results from the global EV-ICD Pivotal Study

血管外ICD的ATP、除颤和安全性能一致：全球EV-ICD关键研究的最终结果

Pacing Performance of the First Leadless Pacemaker Communicating with an SICD from the full cohort of the MODULAR ATP study

MODULAR ATP研究全队列中第一个与SICD通信的无导线起搏器的起搏性能

Death and Neurological Outcome in Patients Delivered to a Cardiac Arrest Centre: Pre-specified secondary analyses of the ARREST Trial

送往心脏骤停中心的患者死亡和神经系统结局：Arrest试验预先指定的二次分析

Resynchronization/defibrillation for Ambulatory heart Failure Trial in patients with Permanent Atrial Fibrillation

永久性心房颤动患者的动态心力衰竭再同步/除颤试验

Pulsed ElectRic FiEld versus Cryoballoon to Treat Paroxysmal Atrial Fibrillation (PERFECT-PAF) Randomized Trial: a Periprocedural Clinical and Cost Analysis

PERFECT-PAF研究——高压脉冲电场 vs. 冷冻球囊治疗阵发性心房颤动的随机试验：围手术期临床和成本分析

Using computed tomogram atrial myocardial thickness maps in cryoballoon pulmonary vein isolation: a randomized clinical trial

计算机断层图心房心肌厚度图在冷冻球囊肺静脉隔离中的应用：一项随机临床试验

A Multicenter Study Comparing the Outcome of Catheter Ablation of Atrial Fibrillation between Cryoballoon and Radiofrequency Ablation in Patients with Heart Failure (CRABL-HF)

多中心研究比较冷冻球囊和射频消融治疗心力衰竭患者心房颤动的结果：CRABL-HF研究

Conduction system pacing vs biventricular resynchronization therapy in systolic dysfunction and wide QRS: CONSYST-CRT.

传导系统起搏与双心室再同步治疗收缩功能障碍和宽QRS：CONSYST-CRT研究

脂质治疗的小型试验、试验更新和其他研究

北京时间：9月2日 18:00-19:00

Cardiovascular Efficacy of Evolocumab in Patients with Obesity:  Updates from FOURIER Trial

依洛尤单抗治疗肥胖患者的心血管疗效：FOURIER试验的最新进展

Alternative LDL cholesterol lowering strategy vs. high-intensity statin strategy: An individual patient data meta-analysis from the randomized RACING and LODESTAR trials

LDL-C降低替代策略 vs. 高强度他汀类药物策略：随机RACING和LODESTAR试验的个体患者数据荟萃分析

Apolipoprotein A-I infusions and cardiovascular outcomes in patients with acute myocardial infarction and hyperlipidemia

载脂蛋白A-I输注与急性心肌梗死合并高脂血症患者的心血管结局

ApoA-I Infusions and Burden of Ischemic Events after Acute Myocardial Infarction

ApoA-I输注与急性心肌梗死后缺血性事件的负担

A phase 3 study to evaluate the efficacy and safety of ARO-APOC3 in adults with familial chylomicronemia syndrome

评估ARO-APOC3治疗成人家族性乳糜微粒血症综合征的疗效和安全性的3期研究

心房颤动的登记、观察和其他研究

北京时间：9月2日 20:45-22:00

Refining the CHA2DS2VASc risk stratification scheme: Shall we drop the Sex Category?

完善CHA2DS2VASc风险分层方案：我们应该取消性别类别吗？

A comparison of vascular brain lesions on magnetic resonance imaging in patients with atrial fibrillation and patients with atherosclerosis

心房颤动和动脉粥样硬化患者脑血管病变的磁共振成像比较

Incidence of atrial fibrillation in cryptogenic stroke with patent foramen ovale closure:the PFO-AF study

卵圆孔未闭的隐源性卒中患者心房颤动发生率：PFO-AF研究

Biomarkers for improved risk prediction and biological insights in patients with atrial fibrillation

用于改善心房颤动患者风险预测和生物学见解的生物标志物

Phenotypes of pharmacological treatment in patients with atrial fibrillation: a latent class analysis from the prospective GLORIA-AF Registry Phase III

心房颤动患者药物治疗的表型：前瞻性GLORIA-AF注册III期研究的潜在类别分析

Longterm 13 Year Outcome of AF Ablation in Elderly Patients - German Ablation Registry

老年患者房颤消融13年远期疗效：德国消融登记研究

关于妊娠期心血管问题的登记、观察和其他研究

北京时间：9月2日 20:45-22:15

Bromocriptine treatment and outcome in patients with peripartum cardiomyopathy: the EORP PPCM registry

溴隐亭治疗围产期心肌病的疗效：EORP PPCM登记研究

Pregnancy in women with prosthetic heart valves: focus on anticoagulation

使用人工心脏瓣膜的女性妊娠：抗凝治疗的重点

Prospective Pakistan registry of echocardiographic screening in asymptomatic pregnant women

巴基斯坦无症状孕妇超声心动图筛查前瞻性登记研究

Pregnancy in women with aortic pathology or genetic predisposition for aortic disease: data from the ESC Registry of Pregnancy and Cardiac disease

患有主动脉病变或有主动脉疾病遗传易感性的女性妊娠：来自ESC妊娠和心脏病登记研究的数据

Pregnancy outcomes in women with heart diseases: Results from the Tamil Nadu Pregnancy and Heart Disease Registry

心脏病女性的妊娠结局：Tamil Nadu妊娠和心脏病登记研究的结果

Artificial intelligence enabled obstetric cardiovascular screening: secondary endpoint results from the SPEC-AI Nigeria randomized clinical trial

人工智能支持的产科心血管筛查：SPEC-AI尼日利亚随机临床试验的次要终点结果

抗血小板和抗血栓疗法的小型试验、试验更新和其他研究

北京时间：9月2日 22:15-23:15

Long-acting Factor XI Inhibition and Periprocedural Bleeding: A Secondary Analysis from AZALEA-TIMI 71

长效XI因子抑制剂与围术期出血：AZALEA-TIMI 71的二次分析

Aspirin and hemocompatibility related adverse events after LVAD implantation in patients with diabetes mellitus, obesity and atrial fibrillation: the ARIES-HM3 randomized clinical trial

糖尿病、肥胖和心房颤动患者LVAD植入后阿司匹林和血液相容性相关不良事件：ARIES-HM3随机临床试验

Efficacy and safety of anticoagulation in patients with device-detected atrial fibrillation by indication for acetylsalicylic acid therapy

根据乙酰水杨酸治疗适应症，对设备检测到的心房颤动患者进行抗凝治疗的有效性和安全性

The Association between Age and Clinical Outcomes in Patients with Subclinical Atrial Fibrillation Treated with Apixaban: Insights from the ARTESiA Trial

阿哌沙班治疗亚临床心房颤动患者的年龄与临床结果的相关性：ARTESiA试验的启示

Changes in Cognitive Function in Patients with Subclinical Atrial Fibrillation Treated with Apixaban or Aspirin: A Sub-Study from the ARTESiA Trial

阿哌沙班或阿司匹林治疗亚临床心房颤动患者认知功能的变化：ARTESiA试验的一项亚组研究

心房颤动的小型试验、试验更新和其他研究

北京时间：9月2日 22:15-23:15

Flecainide to prevent atrial arrhythmia after patent foramen ovale closure, the AFLOAT randomized study

氟卡尼预防卵圆孔未闭后房性心律失常：AFLOAT随机研究

Enhanced Detection and Quickened Diagnosis of Atrial Fibrillation Using Apple Watch: A Randomized Controlled Trial

使用Apple Watch增强心房颤动的检测和快速诊断：一项随机对照试验

Detection of silent atrial fibrillation in high stroke risk patients using bed sensor and smartphone app: the CARE-DETECT trial

使用床传感器和智能手机应用程序检测卒中高危患者的无症状心房颤动：CARE-DETECT试验

Atrial fibrillation follow-up investigation to recover memory and learning trial

心房颤动恢复记忆和学习的随访研究

Manual chest PRESSURE during direct current cardioversion for Atrial Fibrillation: a randomized control trial (PRESSURE-AF).

心房颤动直流电复律期间的手动胸部压力：PRESSURE-AF随机对照试验